- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03146481
Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis
November 4, 2017 updated by: Nermeen AwadAllah Abbas Ibrahim, Cairo University
Effect of Pre-operative Aceclofenac on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial
The aim of this randomized, double-blinded, controlled study is to evaluate the effect of pre-operative oral aceclofenac on the success of the inferior alveolar nerve block with 2% Mepivacaine containing 100,000 Epinephrine for patients with symptomatic irreversible pulpitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- The aim of this randomized, double-blinded, controlled study is to evaluate the effect of pre-operative oral aceclofenac on the success of the inferior alveolar nerve block with 2% Mepivacaine containing 100,000 Epinephrine for patients with symptomatic irreversible pulpitis.
- Patients will be clinically and radiographically examined and their eligibility will be assessed and preoperative pain will be measured using Heft-Parker VAS. Eligible patients will be treated in one visit.
- Patients will be randomly assigned to one of 2 groups: experimental group (taking a 100 mg of Aceclofenac) and the control group (taking a placebo tablet). Each tablet will be taken one hour before starting treatment. After 15 minutes of the initial inferior alveolar nerve block (IANB), the teeth will be examined using a cold pulp sensitivity test; in case of no or mild pain, the treatment will be initiated otherwise, additional IANB will be administered.
- During root canal treatment, no to mild pain response will be considered success. In case of failure, supplemental anesthesia will be administrated.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11553
- Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients in good health (American Society of Anesthesiologists Class I or Class II).
- Patients having symptomatic irreversible pulpitis in one of their mandibular molars
- Age is 18 years or older.
- Patients who can understand Heft- Parker Visual Analogue Scales.
- Patients able to sign informed consent.
Exclusion Criteria:
- Patients allergic to aceclofenac or Mepivacaine.
- Pregnant or nursing women.
- Patients having active pain in more than one molar in the same quadrant.
- Administration of analgesics within 12 h before the administration of the study drug.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: placebo
Placebo
|
Placebo tablet given one hour before starting the root canal treatment
|
EXPERIMENTAL: Aceclofenac
Aceclofenac 100 mg tablet
|
Aceclofenac 100 mg tablet given one hour before starting the root canal treatment
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anesthetic success
Time Frame: intraoperative
|
Success of mandibular inferior alveolar nerve block anesthesia during access cavity preparation and instrumentation which will be measured with Heft-parker VAS in which no or mild pain will be considered as anesthetic success and moderate or severe pain will be considered as anesthetic failure.
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain on injection of inial IANB
Time Frame: intraoperative
|
Pain on injection of inial IANB will be measured with Heft-Parker VAS
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ramachandran A, Khan SI, Mohanavelu D, Kumar KS. The efficacy of pre-operative oral medication of paracetamol, ibuprofen, and aceclofenac on the success of maxillary infiltration anesthesia in patients with irreversible pulpitis: A double-blind, randomized controlled clinical trial. J Conserv Dent. 2012 Oct;15(4):310-4. doi: 10.4103/0972-0707.101881.
- Jena A, Shashirekha G. Effect of preoperative medications on the efficacy of inferior alveolar nerve block in patients with irreversible pulpitis: A placebo-controlled clinical study. J Conserv Dent. 2013 Mar;16(2):171-4. doi: 10.4103/0972-0707.108209.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (ACTUAL)
July 1, 2017
Study Completion (ACTUAL)
July 1, 2017
Study Registration Dates
First Submitted
May 7, 2017
First Submitted That Met QC Criteria
May 9, 2017
First Posted (ACTUAL)
May 10, 2017
Study Record Updates
Last Update Posted (ACTUAL)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 4, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2015-5-145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irreversible Pulpitis
-
Nebu PhilipChristian Dental CollegeNot yet recruitingIrreversible PulpitisIndia
-
Qatar UniversityCairo University; NYU Langone Health; Mahidol University; Jordan University of... and other collaboratorsRecruitingIrreversible PulpitisQatar
-
University of MalayaRecruitingPulpitis - IrreversibleMalaysia
-
Cairo UniversityNot yet recruiting
-
British University In EgyptRecruitingPulpitis - IrreversibleEgypt
-
Postgraduate Institute of Dental Sciences RohtakRecruitingPulpitis - IrreversibleIndia
-
Liaquat University of Medical & Health SciencesCompletedPulpitis - IrreversiblePakistan
-
Alexandria UniversityActive, not recruitingIrreversible PulpitisEgypt
-
Maharishi Markendeswar University (Deemed to be...CompletedPulpitis - IrreversibleIndia
-
Suez Canal UniversityUnknown
Clinical Trials on Aceclofenac
-
Daewon Pharmaceutical Co., Ltd.CompletedOsteoarthritis of KneeKorea, Republic of
-
Pharmtechnology LLCX7 Clinical Research LLCCompletedBioequivalenceRussian Federation
-
Dong-A ST Co., Ltd.CompletedNSAID-associated Gastroduodenal InjuryKorea, Republic of
-
Dong Wha Pharmaceutical Co. Ltd.UnknownHealthyKorea, Republic of
-
Chang Gung Memorial HospitalRecruitingFrozen ShoulderTaiwan
-
Cairo UniversityCompletedSymptomatic Irreversible PulpitisEgypt
-
Onconic Therapeutics Inc.CompletedAnti-Ulcer AgentsKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korea University Guro Hospital; Gangnam... and other collaboratorsCompletedLow Back PainKorea, Republic of
-
NVP HealthcareWithdrawnHealthyKorea, Republic of
-
Il-Yang Pharm. Co., Ltd.CompletedDrug Interaction PotentiationKorea, Republic of